Yupeng Chen

24PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical devicesCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jan 19, 2026
Integrating Proteomics and Predictive Model: Elucidating the Role of Aminated Nanodiamonds in Suppressing Prostate Cancer Growth.

Wenjie Xie, Qianfeng Xu, Zeheng Tan

|Nov 13, 2025
Targeting FGFR1 enhances olaparib sensitivity via MAPK-mediated BRCA2 downregulation in mCRPC.

Jian Chen, Jiarun Lai, Yupeng Chen

|Aug 13, 2025
Purine Nucleoside Phosphorylase (PNP) as a Biomarker and Therapeutic Target in Muscle-Invasive Bladder Cancer.

Yanfei Chen, Peiyi Xian, Jianming Lu

|Oct 22, 2024
Identifying <i>CDCA3</i> as a pivotal biomarker for predicting outcomes and immunotherapy efficacy in pan-renal cell carcinoma.

Hongwei Luo, Huichan He, Zezhen Liu

|Jul 23, 2024
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma.

Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu

|May 07, 2024
A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy.

Wenjie Xie, Yixun Zhang, Qianfeng Xu

Pageof 4

Frequent Collaborators

3 joint publications

Jianming Lu

2 joint publications

Jian Chen

2 joint publications

Yangjia Zhuo

2 joint publications

Xuejin Zhu